NCT06849271

Brief Summary

The purpose of this clinical investigation, HYROS-MTC-I, is to confirm the effectiveness of the combined use of ROB-Bitrack System, its corresponding ElectroSurgical Endoscopic instruments and Non-ElectroSurgical Endoscopic instruments (ESE and NESE instruments respectively) and accessories in a multicentric study in urologic procedures with the indication of a robot assisted laparoscopic Radical/simple nephrectomy (RN), Partial nephrectomy (PN), Radical Prostatectomy (RP or P), and when it applies Lysis of Adhesions (during a PN, RN or RP or P to cut the adhesions and reach the organ) and Lymphadenectomy (only after a P with the aim to remove the lymph nodes) . HYROS-MTC-I is a confirmatory study in which the hypothesis of the primary endpoint is that: "Operative time (OT) with Bitrack System and its ESE/NESE Instruments and accessories will be equal or lower than superiority margin time of State of the Art (SoTA) of MIRS (Minimally Invasive Robotic Surgery) independently of the user experience and site". This study includes the data collected up to 30 days post-surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 9, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

January 15, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 27, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

10 months

First QC Date

January 9, 2025

Last Update Submit

July 28, 2025

Conditions

Keywords

Radical nephrectomyPartial nephrectomyRadical prostatectomyLymphadenectomyLysis of adhesionsRobotic surgeryMinimal Invasive surgeryMinimal Invasive robotic surgeryUrology

Outcome Measures

Primary Outcomes (1)

  • Operative time (OT) with ROB-Bitrack System and its ESE/NESE Instruments and accessories to perform the surgeries.

    Evaluation of Operative time from first skin incision to last skin suture of the procedure.It is hypothesized that Operative time (OT) will be equal or lower than the maximum time as defined by the State of the Art (SoTA) of MIRS independently of the user experience and site.

    During the procedure

Study Arms (1)

Patients surgically treated with ROB-Bitrack System and ESE/ NESE instruments and accessories

EXPERIMENTAL
Procedure: Radical Nephrectomy (RN)Procedure: Partial nephrectomy (PN)Procedure: Radical Prostatectomy (RP)

Interventions

Complete remove of the kidney. In addition as part of the intervention, a procedure termed "Lysis of abdominal adhesions" may be performed according to patient medical condition and/or surgeon criteria.

Patients surgically treated with ROB-Bitrack System and ESE/ NESE instruments and accessories

Partial remove of a section in the kidney. In addition, as part of the intervention, a procedure termed "Lysis of abdominal adhesions" may be performed according to patient medical condition and/or surgeon criteria.

Patients surgically treated with ROB-Bitrack System and ESE/ NESE instruments and accessories

Complete remove of the prostate gland. In addition as part of the intervention, two procedures termed "Lysis of abdominal adhesions" and/or "Lymphadenectomy " (removal of regional lymph nodes) may be performed according to patient medical condition and/or surgeon criteria.

Patients surgically treated with ROB-Bitrack System and ESE/ NESE instruments and accessories

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult subjects between 18 and 90 years old who have provided written informed consent prior to any clinical investigation related procedures.
  • Subjects who have been scheduled for a laparoscopic Radical/simple Nephrectomy surgery, laparoscopic Partial Nephrectomy or laparoscopic Radical Prostatectomy following the surgeon criteria.
  • Ability and willingness to comply with all study requirements to be evaluated for each study visit.

You may not qualify if:

  • Pregnant or breastfeeding women at the time of the surgery.
  • Subjects with severe concomitant illness that, at PrincipaI investigator´s discretion, increases risk of therapeutic interventions or that have been submitted to multiple prior surgeries.
  • Subjects admitted to the hospital due to an emergency situation.
  • Subjects with untreated active infection.
  • Subject with known allergy to some of the device components (i.e., stainless steel, etc.)
  • Subjects not suitable to undergo Minimally Invasive Surgery (MIS)/ Minimally Invasive Robotic Surgery (MIRS), according to medical criteria.
  • Subjects with life expectancy inferior to 3 months.
  • Subjects with a BMI (Body Mass Index) ≥ 40
  • Subjects with any contraindication for the use of the ROB-Bitrack System and the ESE/NESE instruments, as specified in the Instructions For Use.
  • Subjects with abuses of active substances or with uncontrolled psychiatric disorders.
  • Subjects with severe cardiopulmonary or coronary artery disease, bleeding disorders or that have been submitted to multiple prior operations.
  • Subjects scheduled for surgeries intended to be in direct contact with the heart, the central circulatory system or the central nervous system.
  • Inability to adhere to study-related procedures.
  • Subjects who participate in another trial which may affect the outcome data on this study or the ability to complete the follow up requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Hospital del Mar

Barcelona, Spain, 08003, Spain

RECRUITING

Hospital Clinic de Barcelona

Barcelona, Spain, 08036, Spain

RECRUITING

Hospital General de Granollers

Granollers, Spain, 08402, Spain

RECRUITING

Hospital de Mataró

Mataró, Spain, 08304, Spain

RECRUITING

Hospital Universitari de Vic

Vic, Spain, 08500, Spain

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single Group Assignment
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2025

First Posted

February 27, 2025

Study Start

January 15, 2025

Primary Completion

November 1, 2025

Study Completion

December 1, 2025

Last Updated

July 31, 2025

Record last verified: 2025-07

Locations